Investigational Drugs List

Groups Distribution
Phase Distribution
Filter Conditions

Investigational Drugs List

Drugs ID CID Drugs Identifier Molecular Formula Molecular Weight Groups US Approved Details
Drug61 80116 Creatine monohydrate NCT02463305 C4H11N3O3 149.15 NULL NULL Details
Drug62 84029 Clarithromycin NCT00355602 C38H69NO13 748.00 approved YES Details
Drug63 119192 Meclinertant NULL C32H31ClN4O5 587.10 NULL NULL Details
Drug64 126941 Methotrexate NCT00035074, NCT02413047, NCT01393405, NCT00498589 C20H22N8O5 454.40 approved YES Details
Drug65 134018 Febuxostat NCT06525974 C16H16N2O3S 316.40 NULL YES Details
Drug66 169535 Ferric maltol NCT05456932, NCT01340872 C18H15FeO9 431.20 NULL YES Details
Drug67 170484 2'-Fucosyllactose NCT03847467 C18H32O15 488.40 NULL NULL Details
Drug68 188824 Propionyl-L-Carnitine NCT01026857, NCT01567956, NCT01538251 C10H19NO4 217.26 NULL NULL Details
Drug69 358641 Cotrimoxazole NCT00355602 C24H29N7O6S 543.60 NULL NULL Details
Drug70 445643 Tacrolimus NCT00643071, NCT00514982, NCT02954159, NCT06867042, NCT00347048 C44H69NO12 804.00 approved|investigational YES Details